Post-Market Clinical Follow-up (PMCF)
A continuous process of proactively collecting and evaluating clinical data on a medical device after it has been placed on the market. PMCF is a mandatory component of post-market surveillance under EU MDR.
Post-Market Clinical Follow-up (PMCF) is a structured, ongoing process for gathering clinical evidence about a medical device's safety and performance once it is in routine clinical use. Under EU MDR, manufacturers must define a PMCF plan as part of their Clinical Evaluation Report and update it throughout the device lifecycle.
PMCF activities
PMCF can include PMCF studies (prospective clinical investigations), PMCF surveys (structured questionnaires to users), literature reviews, registry data analysis, and real-world evidence collection. The scope and intensity of PMCF depend on the device's risk class, novelty, and clinical evidence gaps identified during pre-market evaluation.
Procurement implications
Sophisticated procurement teams evaluate PMCF data when assessing device safety and long-term clinical performance. Suppliers who can present robust PMCF results — demonstrating sustained safety and effectiveness in real-world use — gain a competitive advantage in tender evaluations, particularly for implantable and high-risk devices.